NCT03751735View on ClinicalTrials.gov

Efficacy of Wharton Jelly in Erectile Dysfunction

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

January 13, 2019

Study Completion Date

February 26, 2019

Conditions
Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Interventions
BIOLOGICAL

Wharton Jelly Mesenchymal stem cells

Intracavernous injection of Wharton Jelly Mesenchymal stem cells.

Trial Locations (1)

11942

Cell Therapy Center, Amman

All Listed Sponsors
lead

Sophia Al-Adwan

OTHER

NCT03751735 - Efficacy of Wharton Jelly in Erectile Dysfunction | Biotech Hunter | Biotech Hunter